Skip Ribbon Commands
Skip to main content
Menu

Grants FY20-21

NMRC

  • “The role of Caveolin-1 in Ocular Neurovascular Coupling”.
    Dr Rachel Chong; S$20,000.00

  • “Evaluation of safety and efficacy of subconjunctival injection of liposomal tacrolimus for allergic conjunctivitis”.
    Prof Jodhbir Mehta; S$208,333.33

  • “Wireless Miniaturised GonioPEN for irido-corneal imaging”.
    A/Prof Shamira Perera; S$208,333.33

  • “Digital technology solutions to improve the vision-specific quality of life and social engagement in the visual impaired older population- a pilot study”
    Dr Anna Tan; S$498,000.00

  • “Optimising Surgical Management and Patient-related Outcomes of Epiretinal Membrane: Predictive Analytics and Randomised Trial”
    Dr Cheung Ning; S$674,938.50

  • “Using Novel imaging biomarkers to predict Vascular Endothelial Growth Factor inhibitor retreatment load for neovascular Age related Macular Degeneration”
    Dr Kelvin Teo; S$375,000.00

  • “Singapore Angle Closure Glaucoma Program: From Genetics to Precision Medicine and Therapy”
    Prof Aung Tin; S$4,160,478.00


A*Star/ Duke-NUS/ MOH/ Others

  • “Transforming vision evaluation and dilation in the care of ophthalmic patients”.
    Dr Gavin Tan; S$49,999.20

SingHealth

  • “From Machine to Machine - Developing a Deep Learning Algorithm for Quantification of Ocular Traits based on Retinal Photographs”.
    Dr Tyler Rim Hyungtaek; S$100,000.00

  • “COVID-19 Pandemic: Triaging of ‘Only Urgent Eye Referrals’ from Polyclinics (TOP) using Retinal Photograph-based Deep Learning”.
    Dr Tham Yih Chung; S$28,500.00

  • “Choroidal All-trans Retinoic Acid Involvement in the Local Control of Eye Growth in Myopia  Development”.
    Dr Jiang Liqin; S$49,500.00

  • “The Role of the Aging Visual Function System on Functional Health in Elderly  Singaporeans”.
    Dr Preeti Gupta; S$149,889.00

  • “Task Shifting intravitreal Injection from Ophthalmologists to Nurses: A Prospective Randomized Non-Inferiority Trial”.
    A/Prof Ian Yeo; S$65,000.00


Commercial

  • “An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost Sustained Release (SR) in Patients with Open Angle Glaucoma (OAG) or Ocular Hypertension (OHT)”
    A/Prof Shamira Perera; S$46,995.33